The Food and Drug Administration has granted Teva Pharmaceuticals USA tentative approval to sell a generic version of Pfizer Inc.'s cholesterol blockbuster, Lipitor.
The agency says Teva's research data shows its pill is safe and effective.
The FDA cannot grant final approval until May 31. India's Ranbaxy Laboratories has the exclusive right to sell generic Lipitor, or atorvastatin, for 180 days after Lipitor's U.S. patent expired on Wednesday, because it was the first company to successfully challenge Lipitor's patent.
Ranbaxy began shipping its version after getting FDA approval late Wednesday. Watson Pharmaceuticals Inc. is selling an authorized generic under a partnership with Pfizer.
Teva USA is part of Israel's Teva Pharmaceutical Industries Ltd.
Concealed Carry: What To Do When Stopped By The Police - Bearing Arms - Concealed Cary, Video
How did the FBI manage to “lose” Sharyl Attkisson’s file?
The Myth of "4 Million Conservative Voters Stayed Home in 2012" | RedState
Doug Giles - Here’s Why Islam Wants Our Heads -- In THEIR Own Words
Adam Baldwin: What's justice versus 'climate justice'?
- What Is Your U.S. Income Percentile Ranking?
Millennials’ New American Dream | Human Events